Study to Optimize the IOL Constant of a New Multifocal Intraocular Lens

NCT05201027 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2022-08-22

No results posted yet for this study

Summary

Prospective, non-comparative, multicenter study on medical device with 6 months follow-up.

Conditions

  • Cataract Senile

Interventions

DEVICE

trifocal intraocular lens

cataract extraction and implantation of a posterior chamber trifocal intraocular lens

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-28
Primary Completion
2022-07-27
Completion
2022-07-27

Countries

  • El Salvador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201027 on ClinicalTrials.gov